Partnership
Rebellions x ZeroPoint
ZeroPoint and Rebellions formed a strategic alliance to develop the next generation of memory-optimized AI accelerators. The collaboration combines ZeroPoint memory compression technology with Rebellions AI chip expertise.
development · Announced · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/rebellions-x-zeropoint.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/rebellions-x-zeropoint
- Revision history: /partnerships/rebellions-x-zeropoint/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
6867b653-a176-48b1-8791-3ccc9f0057b8- Type
- development
- Status
- Announcedoperating
Who’s involved
Rebellionstechnology provider
Korean AI chip startup; ATOM and ION accelerators for data center and edge inference. Merger with [Sapeon](/companies/sapeon) announced 2024.
Most-frequent partners
- AWS1
Off-registry parties
- ZeroPoint · co developer
Related partnerships
Other deals between the same parties
- Rebellions x Penguin Solutions x SK TelecomRebellions + Penguin Solutions + SK Telecomtechnology—operating
- Rebellions x PegatronRebellions + Pegatronmanufacturing—operating
- technology—just announced
Other partnerships of Rebellions
- Rebellions x Penguin Solutions x SK TelecomRebellions + Penguin Solutions + SK Telecomtechnology—operating
- Rebellions x PegatronRebellions + Pegatronmanufacturing—operating
- technology—just announced
Recent partnerships of the same kind
- Kautex Textron RESiLiTE Horizon EuropeKautex Textron + Horizon Europe EU Programmedevelopment—operating
- Canvas x USG CorporationCanvas + USG Corporationdevelopment—operating
- Threod Systems x First ShieldFirst Shield + Threod Systemsdevelopment—operating
- RIKEN BDR x Otsuka Pharmaceutical CollaborationRIKEN Center for Biosystems Dynamics + Otsuka Pharmaceuticaldevelopment—operating
- Entegris x SEMATECHEntegris + SEMATECHdevelopment—operating
- development—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.